Breaking News
Get Actionable Insights with InvestingPro+: Start 7 Day FREE Trial Register here
Investing Pro 0
Ad-Free Version. Upgrade your Investing.com experience. Save up to 40% More details
Close

Coloplast A/S (COLOb)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Add to/Remove from Watchlist Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
865.8 +6.6    +0.77%
09:43:26 - Real-time Data. Currency in DKK ( Disclaimer )
Type:  Equity
Market:  Denmark
ISIN:  DK0060448595 
S/N:  198000000
  • Volume: 477,455
  • Bid/Ask: 0.0 / 0.0
  • Day's Range: 850.0 - 873.6
Coloplast 865.8 +6.6 +0.77%
Summary:Buy
Moving Averages:NeutralBuy (6)Sell (6)
Technical Indicators:Strong BuyBuy (9)Sell (0)

Pivot PointsMay 17, 2022 01:26PM GMT

Name S3 S2 S1 Pivot Points R1 R2 R3
Classic 865.2 866.7 869.2 870.7 873.2 874.7 877.2
Fibonacci 866.7 868.2 869.2 870.7 872.2 873.2 874.7
Camarilla 870.7 871.1 871.4 870.7 872.2 872.5 872.9
Woodie's 865.8 867.0 869.8 871.0 873.8 875.0 877.8
DeMark's - - 870.0 871.1 874.0 - -

Technical IndicatorsMay 17, 2022 01:26PM GMT

Name Value Action
RSI(14) 54.569 Neutral
STOCH(9,6) 73.618 Buy
STOCHRSI(14) 85.502 Overbought
MACD(12,26) 1.700 Buy
ADX(14) 29.130 Buy
Williams %R -20.000 Buy
CCI(14) 88.4125 Buy
ATR(14) 8.5429 Less Volatility
Highs/Lows(14) 0.7714 Buy
Ultimate Oscillator 55.255 Buy
ROC 0.508 Buy
Bull/Bear Power(13) 13.1300 Buy

Buy: 9

Sell: 0

Neutral: 1


Summary:Strong Buy

Moving AveragesMay 17, 2022 01:26PM GMT

Period Simple Exponential
MA5 870.0
Sell
868.0
Buy
MA10 863.8
Buy
865.4
Buy
MA20 860.8
Buy
861.9
Buy
MA50 860.8
Buy
875.9
Sell
MA100 917.5
Sell
911.2
Sell
MA200 979.9
Sell
943.5
Sell

Buy: 6

Sell: 6


Summary:Neutral

Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

COLOb Comments

Write your thoughts about Coloplast A/S
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Hans Petersen
Hans Petersen Oct 09, 2018 1:34PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Har lige udbetalt udbytte, så nu kommer den til at stige frem til nytår.
Stefano Strazzari
Stefano Strazzari Oct 09, 2018 1:34PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Do you really think so, Hans?Considering the P/E ratio, Coloplast is really very expensive: at the level of luxury shares. It would seem very difficult to increase its value. I would be very happy, anyway ........ What do you think?
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email